Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Another case involving some of our investors
Anyone think that the "good ole boy network" may take over TPL/PDS? Why in the world did they put anything in the report about preferred shares if they were NOT getting ready to issue some---who would get them? Would that also be the "gobn"?? GL, ads
Share
New Message
Please login to post a reply